Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pluri Inc. Director's Dealing 2017

Dec 14, 2017

6990_dirs_2017-12-14_e5092f8a-70c8-483e-b3b0-22b650c94725.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PLURISTEM THERAPEUTICS INC (PSTI)
CIK: 0001158780
Period of Report: 2017-12-14

Reporting Person: Kwiat Moria (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-12-14 Common Stock A 90000 Acquired 277500 Direct

Footnotes

F1: The shares vest as follows: 12.5% on the 6 month anniversary of the date of grant and the remaining shares vest in 14 equal installments every 3 months thereafter.